PM of $PINK Shares for the Cure. Healthcare Hedgefund Manager for past 20 yrs. Scientist, Virologist, Humanitarian, Troglodyte w/a keyboard.
Cite asCryptoQuant has tracked the directional calls on NVDA by @Mike_Taylor1972 on X since Jul 2026: not yet scored on NVDA (as of Nov 11, 2026).
4 NVDA calls on record, a thin history.
Relative view by default: fewer than 30 NVDA calls or days on record.
Sentiment timeline shows relative sentiment within this analyst's history. A perma-bull showing 8 bullish : 2 bearish in a bear market sets that as their baseline. If you notice any errors, claim @Mike_Taylor1972 to submit corrections.
Hover the chart to read the thesis of that period · click a day to pin it
$NVDA - as I put the pieces together on how the AI bubble pops, I realize NVDA could take a last gasp effort to rope Insurance cos into the datactr trade w first-loss debt. -keep an eye out for that.
View original →I sense $NVDA may take extreme measures, as if guaranteeing returns to their client debt investors is not extreme enough. Extreme-er on the Horizon!! (IMHO We have an inventory problem, soon to be a rev rec problem). https://t.co/OdhAzWdCwY
View original →The problem with data ctr collateral, rev recognition, neg pricing and $NVDA: Debt is “Secured”: Much neocloud debt is secured with a guarantee net-net by $NVDA. The collateral is the GPUs themselves. Rev Recognition “oops I did it again”: Imagine $NVDA projects 100 units sold (at 100% growth) for 2027. BUT what if for one reason or another, only 60 get placed into slowly-assembled data ctrs? Production, pricing and scarcity of supply abruptly ends if the parabolic build of data centers slow. Negative Pricing begins for GPUs, memory …and importantly, the collateral. The Collateral of that data ctr loan is a GPU that now has LOWER value as supply constraint abates. In fact, that collateral is terrible, as if one calls in on any, they ALL tank in value, accelerating the daisy chain. What worries me greatly, is as I have pointed this out to my peers, very few have thought this through. “Yeah but it’s $NVDA, a $5trn company”. My only answer: “NOT if datactr growth is slowing, bc they will immediately lose pricing power, margins, and are on the hook for SOOOO much collateral, it’s mind bending” Side note: There is NO government rescue for this one. Now- get in there and tell me how I am an idiot. Beware, there is a queue!
View original →$NVDA vs $CSCO (circa 2000) are not parallels. $CSCO had an order book +70% growth into 2001 and by the end was -30%. $NVDA has an orderbook +100%... but has financed much of it, and those chips ARE the collateral, if demand falls, the value of collateral falls. https://t.co/Q5D7GMLxlt
View original →$NVDA: it is so extremely rare that the biggest mega-cap co takes up numbers SO much and the masses of active managers do not believe it. In fact, in 30yrs, I have never seen such a revolt by active mgrs. What do you all think is "the problem"?
View original →
